Glaukos Balance Sheet Health
Financial Health criteria checks 5/6
Glaukos has a total shareholder equity of $765.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $987.0M and $221.8M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$274.79m |
| Equity | US$765.11m |
| Total liabilities | US$221.85m |
| Total assets | US$986.96m |
Recent financial health updates
Companies Like Glaukos (NYSE:GKOS) Can Afford To Invest In Growth
Apr 22
Does Glaukos (NYSE:GKOS) Have A Healthy Balance Sheet?
Jan 17Is Glaukos (NYSE:GKOS) Using Debt In A Risky Way?
Sep 18Recent updates
Glaukos Corporation: Delivering Consistent Growth
Jun 24Why We're Not Concerned About Glaukos Corporation's (NYSE:GKOS) Share Price
Jun 16Companies Like Glaukos (NYSE:GKOS) Can Afford To Invest In Growth
Apr 22
Launch Of iDose TR And Epioxa Will Transform Eye Treatments By 2025
Anticipated launches of iDose TR and Epioxa could significantly boost revenue and strengthen market position in glaucoma and corneal health sectors.Glaukos Corporation (NYSE:GKOS) Shares Slammed 26% But Getting In Cheap Might Be Difficult Regardless
Feb 28Glaukos Corporation (NYSE:GKOS) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Feb 22Does Glaukos (NYSE:GKOS) Have A Healthy Balance Sheet?
Jan 17Are Investors Undervaluing Glaukos Corporation (NYSE:GKOS) By 50%?
Dec 25Glaukos: Still Bullish, But Embedded Expectations Are Now High
Dec 21Revenues Tell The Story For Glaukos Corporation (NYSE:GKOS)
Dec 03Is Glaukos (NYSE:GKOS) Using Debt In A Risky Way?
Sep 18Glaukos Corporation: Ripe For Some Consolidation
Sep 11Glaukos Stock: Still Unproven Whether A New Bull Market Has Begun
May 30Glaukos: Remains A Hold Due To High Valuation And Negative Profitability
Jan 09Glaukos: Continued Growth Rates, Regulatory Tailwinds, And Support
Sep 01Glaukos: Revising To Buy On These 3 Catalytic Factors
Jun 16Financial Position Analysis
Short Term Liabilities: GKOS's short term assets ($436.1M) exceed its short term liabilities ($79.1M).
Long Term Liabilities: GKOS's short term assets ($436.1M) exceed its long term liabilities ($142.7M).
Debt to Equity History and Analysis
Debt Level: GKOS is debt free.
Reducing Debt: GKOS has no debt compared to 5 years ago when its debt to equity ratio was 27.8%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GKOS has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if GKOS has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/08/28 20:41 |
| End of Day Share Price | 2025/08/28 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Glaukos Corporation is covered by 29 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ishan Majumdar | Baptista Research |
| Ravi Misra | Berenberg |
| Joanne Wuensch | BMO Capital Markets Equity Research |